Treatment Efficacy of Tension Type Headache After Application of Sub-occipital Muscle Inhibition Technique Associated With Interferential Electrotherapy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Tension-Type Headache
- Sponsor
- Universidad Católica San Antonio de Murcia
- Enrollment
- 29
- Locations
- 1
- Primary Endpoint
- Pain
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The main objective of this study is to determine the effects caused in neck movement, neck pain, headache in patients with tension type headache and cervicogenic headache after application of sub-occipital muscle inhibition technique associated with interferential electrotherapy.
Detailed Description
This study is based on the combined application of sub-occipital muscle inhibition technique associated with interferential electrotherapy improves symptoms in patients with tension type headache and cervicogenic headache. The purposes of this study are: * Evaluate the effectiveness of treatment based on the combined application of sub-occipital muscle inhibition technique associated with interferential electrotherapy in patients with tension type headache. * Evaluate the effects of treatment caused in upper cervical movement. * Evaluate the effects of treatment caused in neck pain. * Evaluate the effects of treatment caused in headache.
Investigators
Raúl Pérez Llanes
Diplomado en Fisioterapia
Universidad Católica San Antonio de Murcia
Eligibility Criteria
Inclusion Criteria
- •Patients diagnosed with tension type headache
- •In prophylactic regimen and with medical control
Exclusion Criteria
- •Patients with neurological or cognitive impairments that prevent understanding the questionnaires
- •Patients diagnosed with other types of headaches
- •Patients who have not signed the informed consent document
Outcomes
Primary Outcomes
Pain
Time Frame: Pain will be assessed at baseline, before and after each session (twice a week for 4 weeks)
Our primary outcome will consist of changes at each session in self-reported pain, which will be measured with a visual analogic scale (VAS).
Anxiety
Time Frame: STAI will be assessed at baseline and after 4 weeks.
Anxiety will be assessed with the State-Trait Anxiety Inventory. This questionnaire is designed for the self-assessment of anxiety (Cronbach's α for this scale ranges from .83 to .92).
Secondary Outcomes
- Headache Disability(HDI will be assessed at baseline and after 4 weeks.)
- Headache Impact Test(HIT-6 will be assessed at baseline and after 4 weeks.)
- Range of Motion(ROM will be assessed at baseline and after 4 weeks.)
- Neck Disability Index(NDI will be assessed at baseline and after 4 weeks.)
- SF-36 Health Survey(SF-36 will be assessed at baseline and after 4 weeks.)
- Depression(BECK II will be assessed at baseline and after 4 weeks.)